Table of Content

Table of Contents



Global Kidney Cancer Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

1 Market Scope

1.1 Product Details and Introduction

1.1.1 Nexavar (Sorafenib) -Product Introduction and Major Manufacturers

1.1.2 Sutent (Sunitinib) -Product Introduction and Major Manufacturers

1.1.3 Afinitor (Everolimus) -Product Introduction and Major Manufacturers

1.1.4 Votrient (Pazopanib) -Product Introduction and Major Manufacturers

1.1.5 Avastin (Bevacizumab) -Product Introduction and Major Manufacturers

1.1.6 Inlyta (Axitinib) -Product Introduction and Major Manufacturers

1.1.7 Torisel (Temsirolimus) -Product Introduction and Major Manufacturers

1.1.8 Proleukin (Aldesleukin) -Product Introduction and Major Manufacturers

1.1.9 Other -Product Introduction and Major Manufacturers

1.2 Market Snapshot

1.2.1 Major Companies Overview

1.2.2 Market Concentration

1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

2 Regional Market Analysis

2.1 China Kidney Cancer Drugs Status and Prospect (2015-2026)

2.1.1 China Kidney Cancer Drugs Market Size and Growth Rate (2015-2026)

2.1.2 China Kidney Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.2 EU Kidney Cancer Drugs Status and Prospect (2015-2026)

2.2.1 EU Kidney Cancer Drugs Market Size and Growth Rate (2015-2026)

2.2.2 EU Kidney Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.3 USA Kidney Cancer Drugs Status and Prospect (2015-2026)

2.3.1 USA Kidney Cancer Drugs Market Size and Growth Rate (2015-2026)

2.3.2 USA Kidney Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.4 Japan Kidney Cancer Drugs Status and Prospect (2015-2026)

2.4.1 Japan Kidney Cancer Drugs Market Size and Growth Rate (2015-2026)

2.4.2 Japan Kidney Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.5 India Kidney Cancer Drugs Status and Prospect (2015-2026)

2.5.1 India Kidney Cancer Drugs Market Size and Growth Rate (2015-2026)

2.5.2 India Kidney Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.6 Southeast Asia Kidney Cancer Drugs Status and Prospect (2015-2026)

2.6.1 Southeast Asia Kidney Cancer Drugs Market Size and Growth Rate (2015-2026)

2.6.2 Southeast Asia Kidney Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.7 South America Kidney Cancer Drugs Status and Prospect (2015-2026)

2.7.1 South America Kidney Cancer Drugs Market Size and Growth Rate (2015-2026)

2.7.2 South America Kidney Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

2.8 Kidney Cancer Drugs Status and Prospect (2015-2026)

2.8.1 Kidney Cancer Drugs Market Size and Growth Rate (2015-2026)

2.8.2 Kidney Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

3 Global Kidney Cancer Drugs Market Assessment by Segment

3.1 Global Kidney Cancer Drugs Capacity and Growth Rate

3.2 Global Kidney Cancer Drugs Sales by Type

3.3 Global Kidney Cancer Drugs Sales Revenue by Type

3.4 Global Kidney Cancer Drugs Consumption by Application

4 Global Kidney Cancer Drugs Market Assessment by Regions

4.1 Global Kidney Cancer Drugs Production Analysis and Forecast by Regions (2015-2026)

4.2 Global Kidney Cancer Drugs Sales Analysis and Forecast by Regions (2015-2026)

4.3 Global Kidney Cancer Drugs Sales Revenue Analysis and Forecast by Regions (2015-2026)

5 Value Chain (Impact of COVID-19)

5.1 Kidney Cancer Drugs Value Chain Analysis

5.1.1 Upstream

5.1.2 Downstream

5.2 COVID-19 Impact on Kidney Cancer Drugs Industry

5.2.1 Industrial Policy Issued Under the Epidemic Situation

5.3 Cost-Under the Epidemic Situation

5.3.1 Cost of Raw Material

5.4 Channel Analysis

5.4.1 Distribution Channel-Under the Epidemic Situation

5.4.2 Distributors

6 Competitive Landscape

6.1 Global Kidney Cancer Drugs Capacity Market Share of Manufacturers (2019-2020)

6.2 Global Kidney Cancer Drugs Sales Market Share of Manufacturers (2019-2020)

6.3 Global Kidney Cancer Drugs Sales Revenue Market Share of Manufacturers (2019-2020)



7 Kidney Cancer Drugs Competitive Analysis

7.1 Pfizer

7.1.1 Pfizer Company Profiles

7.1.2 Pfizer Product Introduction

7.1.3 Pfizer Kidney Cancer Drugs Production, Revenue (2015-2020)

7.1.4 SWOT Analysis

7.2 Abbott Laboratories

7.2.1 Abbott Laboratories Company Profiles

7.2.2 Abbott Laboratories Product Introduction

7.2.3 Abbott Laboratories Kidney Cancer Drugs Production, Revenue (2015-2020)

7.2.4 SWOT Analysis

7.3 Glaxosmithkline PLC

7.3.1 Glaxosmithkline PLC Company Profiles

7.3.2 Glaxosmithkline PLC Product Introduction

7.3.3 Glaxosmithkline PLC Kidney Cancer Drugs Production, Revenue (2015-2020)

7.3.4 SWOT Analysis

7.4 Novartis AG

7.4.1 Novartis AG Company Profiles

7.4.2 Novartis AG Product Introduction

7.4.3 Novartis AG Kidney Cancer Drugs Production, Revenue (2015-2020)

7.4.4 SWOT Analysis

7.5 Bayer AG

7.5.1 Bayer AG Company Profiles

7.5.2 Bayer AG Product Introduction

7.5.3 Bayer AG Kidney Cancer Drugs Production, Revenue (2015-2020)

7.5.4 SWOT Analysis

7.6 Active Biotech

7.6.1 Active Biotech Company Profiles

7.6.2 Active Biotech Product Introduction

7.6.3 Active Biotech Kidney Cancer Drugs Production, Revenue (2015-2020)

7.6.4 SWOT Analysis

7.7 Amgen

7.7.1 Amgen Company Profiles

7.7.2 Amgen Product Introduction

7.7.3 Amgen Kidney Cancer Drugs Production, Revenue (2015-2020)

7.7.4 SWOT Analysis

7.8 Cipla Limited

7.8.1 Cipla Limited Company Profiles

7.8.2 Cipla Limited Product Introduction

7.8.3 Cipla Limited Kidney Cancer Drugs Production, Revenue (2015-2020)

7.8.4 SWOT Analysis

7.9 F. Hoffmann-La Roche

7.9.1 F. Hoffmann-La Roche Company Profiles

7.9.2 F. Hoffmann-La Roche Product Introduction

7.9.3 F. Hoffmann-La Roche Kidney Cancer Drugs Production, Revenue (2015-2020)

7.9.4 SWOT Analysis

7.10 Genentech

7.10.1 Genentech Company Profiles

7.10.2 Genentech Product Introduction

7.10.3 Genentech Kidney Cancer Drugs Production, Revenue (2015-2020)

7.10.4 SWOT Analysis

7.11 Prometheus Laboratories

7.12 Exelixis

7.13 Onyx Pharmaceuticals

7.14 Aveo Pharmaceuticals

7.15 Immatics Biotechnologies

8 Conclusion

List of Figure

List of Tables and Figures



Figure Product Introduction

Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)

Figure Global Kidney Cancer Drugs Production Market Share of Top 5 Players

Table CAGR of Major Market (2021-2026)

Table CAGR in Terms of Production of Each Type (2015-2026)

Table CAGR in Terms of Production of Each Application (2015-2026)

Table Global Kidney Cancer Drugs Sales (K Unit) by Type (2015-2026)

Figure Global Kidney Cancer Drugs Sales (K Unit) and Growth Rate (2015-2026)

Figure Global Kidney Cancer Drugs Sales Market Share (%) by Type (2019 -2020)

Table Global Kidney Cancer Drugs Sales Value (Million USD) by Type (2015-2026)

Figure Global Kidney Cancer Drugs Sales Value (Million USD) and Growth Rate (2015-2026)

Figure Global Kidney Cancer Drugs Sales Value Market Share (%) by Type (2019-2020)

Table Global Kidney Cancer Drugs Sales (K Unit) by Application (2015-2026)

Figure China Kidney Cancer Drugs Production Value (Million USD) and Growth Rate (2015-2026)

Table China Kidney Cancer Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure EU Kidney Cancer Drugs Production Value (Million USD) and Growth Rate (2015-2026)

Table EU Kidney Cancer Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure North America Kidney Cancer Drugs Production Value (Million USD) and Growth Rate (2015-2026)

Table North America Kidney Cancer Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure Japan Kidney Cancer Drugs Production Value (Million USD) and Growth Rate (2015-2026)

Table Japan Kidney Cancer Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure India Kidney Cancer Drugs Production Value (Million USD) and Growth Rate (2015-2026)

Table India Kidney Cancer Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure Southeast Asia Kidney Cancer Drugs Production Value (Million USD) and Growth Rate (2015-2026)

Table Southeast Asia Kidney Cancer Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure South America Kidney Cancer Drugs Production Value (Million USD) and Growth Rate (2015-2026)

Table South America Kidney Cancer Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)

Figure Middle East and Africa Kidney Cancer Drugs Production Value (Million USD) and Growth Rate (2015-2026)

Table Middle East and Africa Kidney Cancer Drugs Local Capacity, Import, Export and Local Consumption (2015-2020)

Table Global Kidney Cancer Drugs Capacity (K Units) and Growth Rate (2015-2026)

Figure Global Kidney Cancer Drugs Capacity (K Units) and Growth Rate (2015-2026)

Table Global Kidney Cancer Drugs Sales (Unit) by Type (2015-2026)

Figure Global Kidney Cancer Drugs Sales(Unit) and Growth Rate (2015-2026)

Table Sales Market Share (%) by Type (2019-2026)

Table Global Kidney Cancer Drugs Sales Revenue (Million USD) by Type (2015-2026)

Figure Global Kidney Cancer Drugs Sales Revenue (Million USD) and Growth Rate (2015-2026)

Table Sales Revenue Market Share (%) by Type (2019-2026)

Table Global Kidney Cancer Drugs Consumption (Unit) by Application (2015-2026)

Figure Global Kidney Cancer Drugs Consumption (Unit) and Growth Rate (2015-2026)

Table Consumption Market Share (%) by Application (2019-2026)

Table Global Kidney Cancer Drugs Production (K Unite) by Regions (2015-2020)

Table Global Kidney Cancer Drugs CAGR (%) in term of Production and Market Share by Regions (2015-2026)

Figure Global Kidney Cancer Drugs Production Share by Regions (2019-2020)

Table Global Kidney Cancer Drugs Sales (K Unite) by Regions (2015-2020)

Table Global Kidney Cancer Drugs CAGR (%) in term of Sales and Market Share by Regions (2015-2026)

Figure Global Kidney Cancer Drugs Sales Share by Regions (2019-2020)

Table Global Kidney Cancer Drugs Sales Revenue (Million USD) by Regions (2015-2020)

Table Global Kidney Cancer Drugs CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)

Figure Global Kidney Cancer Drugs Sales Revenue Share by Regions (2019-2020)

Figure Value Chain Structure of Kidney Cancer Drugs

Table Value Chain

Table Key Suppliers of Raw Material/Components

Table Key Downstream Customer in Each Application Field

Table Industry News List of Kidney Cancer Drugs

Figure Cost Structure of Kidney Cancer Drugs in 2020

Table Global Kidney Cancer Drugs Capacity Share of Manufacturers (2019-2020)

Figure Global Kidney Cancer Drugs Capacity Share of Manufacturers (2019-2020)

Table Global Kidney Cancer Drugs Sales Market Share of Manufacturers (2019-2020)

Figure Global Kidney Cancer Drugs Sales Market Share of Manufacturers (2019-2020)

Table Global Kidney Cancer Drugs Sales Revenue Market Share of Manufacturers (2019-2020)

Figure Global Kidney Cancer Drugs Sales Revenue Market Share of Manufacturers (2019-2020)

Figure Global Kidney Cancer Drugs Sales Value (Million USD), Growth Rate & Market Share (2021-2026)

Table Pfizer Profiles

Table Pfizer Kidney Cancer Drugs Product Introduction

Table Pfizer Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Pfizer SWOT Analysis

Table Abbott Laboratories Profiles

Table Abbott Laboratories Kidney Cancer Drugs Product Introduction

Table Abbott Laboratories Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Abbott Laboratories SWOT Analysis

Table Glaxosmithkline PLC Profiles

Table Glaxosmithkline PLC Kidney Cancer Drugs Product Introduction

Table Glaxosmithkline PLC Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Glaxosmithkline PLC SWOT Analysis

Table Novartis AG Profiles

Table Novartis AG Kidney Cancer Drugs Product Introduction

Table Novartis AG Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Novartis AG SWOT Analysis

Table Bayer AG Profiles

Table Bayer AG Kidney Cancer Drugs Product Introduction

Table Bayer AG Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Bayer AG SWOT Analysis

Table Active Biotech Profiles

Table Active Biotech Kidney Cancer Drugs Product Introduction

Table Active Biotech Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Active Biotech SWOT Analysis

Table Amgen Profiles

Table Amgen Kidney Cancer Drugs Product Introduction

Table Amgen Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Amgen SWOT Analysis

Table Cipla Limited Profiles

Table Cipla Limited Kidney Cancer Drugs Product Introduction

Table Cipla Limited Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Cipla Limited SWOT Analysis

Table F. Hoffmann-La Roche Profiles

Table F. Hoffmann-La Roche Kidney Cancer Drugs Product Introduction

Table F. Hoffmann-La Roche Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure F. Hoffmann-La Roche SWOT Analysis

Table Genentech Profiles

Table Genentech Kidney Cancer Drugs Product Introduction

Table Genentech Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Genentech SWOT Analysis

Table Prometheus Laboratories Profiles

Table Prometheus Laboratories Kidney Cancer Drugs Product Introduction

Table Prometheus Laboratories Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Prometheus Laboratories SWOT Analysis

Table Exelixis Profiles

Table Exelixis Kidney Cancer Drugs Product Introduction

Table Exelixis Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Exelixis SWOT Analysis

Table Onyx Pharmaceuticals Profiles

Table Onyx Pharmaceuticals Kidney Cancer Drugs Product Introduction

Table Onyx Pharmaceuticals Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Onyx Pharmaceuticals SWOT Analysis

Table Aveo Pharmaceuticals Profiles

Table Aveo Pharmaceuticals Kidney Cancer Drugs Product Introduction

Table Aveo Pharmaceuticals Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Aveo Pharmaceuticals SWOT Analysis

Table Immatics Biotechnologies Profiles

Table Immatics Biotechnologies Kidney Cancer Drugs Product Introduction

Table Immatics Biotechnologies Kidney Cancer Drugs Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Figure Immatics Biotechnologies SWOT Analysis